NeoGenomics, Inc. Increase Decrease In Operating Lease Liability
NeoGenomics, Inc. (NEO) reported Increase Decrease In Operating Lease Liability of -$2.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-28
- NeoGenomics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.30M, a 243.96% decline year-over-year.
- NeoGenomics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$1.30M.
- NeoGenomics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.23M.
- NeoGenomics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$795.00K.
- NeoGenomics, Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.21M.
- NeoGenomics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$6.00M.
- NeoGenomics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$7.62M.
- NeoGenomics, Inc. increase decrease in operating lease liability for fiscal 2022 was -$8.56M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$2.60M 10-Q · filed 2026-07-28 | -$3.83M derived: sum of 3 quarters · filed 2026-07-28 | -$4.63M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$1.30M 10-Q · filed 2026-04-28 | -$2.53M derived: sum of 2 quarters · filed 2026-04-28 | -$3.33M derived: sum of 3 quarters · filed 2026-04-28 | -$2.42M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.03M derived: sum of 2 quarters · filed 2026-02-17 | -$1.13M derived: sum of 3 quarters · filed 2026-07-28 | -$2.21M 10-K · filed 2026-02-17 |
| 2025-09-30 | -$795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $108.00K derived: sum of 2 quarters · filed 2026-07-28 | -$982.00K 10-Q · filed 2025-10-28 | -$2.69M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $903.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$187.00K 10-Q · filed 2026-07-28 | -$1.90M derived: sum of 3 quarters · filed 2026-07-28 | -$2.88M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | -$1.09M 10-Q · filed 2026-04-28 | -$2.80M derived: sum of 2 quarters · filed 2026-04-28 | -$3.78M derived: sum of 3 quarters · filed 2026-04-28 | -$5.66M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.69M derived: sum of 2 quarters · filed 2026-02-17 | -$4.57M derived: sum of 3 quarters · filed 2026-02-17 | -$6.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$979.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$2.85M derived: sum of 2 quarters · filed 2025-10-28 | -$4.29M 10-Q · filed 2025-10-28 | -$6.04M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$3.31M 10-Q · filed 2025-07-29 | -$5.06M derived: sum of 3 quarters · filed 2026-02-17 | -$7.64M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$1.43M 10-Q · filed 2025-04-29 | -$3.18M derived: sum of 2 quarters · filed 2026-02-17 | -$5.76M derived: sum of 3 quarters · filed 2026-02-17 | -$7.33M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$4.33M derived: sum of 2 quarters · filed 2026-02-17 | -$5.90M derived: sum of 3 quarters · filed 2026-02-17 | -$7.62M 10-K · filed 2026-02-17 |
| 2023-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$4.15M derived: sum of 2 quarters · filed 2024-11-05 | -$5.87M 10-Q · filed 2024-11-05 | -$7.34M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$3.29M 10-Q · filed 2024-07-30 | -$4.76M derived: sum of 3 quarters · filed 2025-02-18 | -$6.92M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | -$1.72M 10-Q · filed 2024-04-30 | -$3.19M derived: sum of 2 quarters · filed 2025-02-18 | -$5.35M derived: sum of 3 quarters · filed 2025-02-18 | -$7.45M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$3.63M derived: sum of 2 quarters · filed 2025-02-18 | -$5.72M derived: sum of 3 quarters · filed 2025-02-18 | -$8.56M 10-K · filed 2025-02-18 |
| 2022-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$4.25M derived: sum of 2 quarters · filed 2023-11-06 | -$7.09M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.93M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$2.83M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$7.88M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | -$4.92M 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |